COVID-19
Arthritis drugs could save lives of COVID-19 patients, study finds
January 8, 2021Medical Communications COVID-19
Two drugs used to treat rheumatoid arthritis could cut COVID-19 hospital stays by as much as 10 days, and save …
New COVID-19 screening hub to be established in Scotland
January 7, 2021COVID-19
A new COVID-19 drug screening and resistance hub, funded by medical research charity LifeArc and the Medical Research Council, is …
Bolivia registers Russia’s Sputnik V COVID-19 vaccine
January 7, 2021COVID-19, Vaccine
Bolivia’s state agency for medicines and health technologies (AGEMED) has registered Russia’s Sputnik V COVID-19 vaccine under emergency use authorisation. …
EU approves Moderna’s COVID-19 vaccine
January 7, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine
The European Commission has granted a Condition Marketing Authorisation (CMA) for Moderna’s COVID-19 vaccine, meaning the jab will soon be …
Pharmafile.com’s weekly COVID-19 news round-up
January 6, 2021Research and Development COVID-19, Vaccine
In the first week of 2021, the global COVID-19 vaccination race continues to dominate the news. The EU states have …
WHO recommends against 12-week delay for COVID-19 vaccine doses
January 6, 2021Research and Development COVID-19, Vaccine, WHO
The WHO has recommended against the UK’s plans to delay second doses of the COVID-19 vaccine by 12 weeks, saying …
Israel authorises Moderna’s COVID-19 vaccine for use
January 5, 2021Manufacturing and Production COVID-19, Moderna, Vaccine
Moderna has announced that Israel’s Ministry of Health (MOH) has authorised the use of its COVID-19 vaccine. Israel has secured …
Emergex to collaborate with Bio-Manguinhos on new COVID-19 vaccine
January 5, 2021Manufacturing and Production COVID-19, Vaccine
Emergex, a company focusing on the development of medicines against viral and bacterial infectious diseases, has announced a collaboration and …
EU states to receive 100m extra doses of Pfizer-BioNTech vaccine
January 4, 2021Sales and Marketing COVID-19, EU, Pfizer, Vaccine
Pfizer and BioNTech have announced they will supply an additional 100 million doses of their COVID-19 vaccine, COMIRNATY, to the …
Concern as India approves COVID-19 vaccine before trial completion
January 4, 2021Sales and Marketing COVID-19, Vaccine
Experts have expressed concern over India’s emergency approval of its homegrown COVID-19 vaccine, Covaxin, before studies have been completed. The …
Moderna’s COVID-19 vaccine achieves over 90% efficacy in Phase III trial
January 4, 2021Sales and Marketing COVID-19, Moderna
Moderna’s COVID-19 vaccine has achieved over 90% efficacy in interim safety and primary efficacy results following its Phase III trial. …
RedHill announces positive top-line data for COVID-19 pneumonia drug
January 4, 2021Sales and Marketing COVID-19
RedHill Biopharma has announced that preliminary top-line data from its US Phase II study with orally-administered opaganib (Yeliva) in patients …
UK becomes first country to roll out Oxford University-AstraZeneca COVID-19 vaccine
January 4, 2021Sales and Marketing AstraZeneca, COVID-19, Vaccine
The UK has become the first country to administer the Oxford University-AstraZeneca COVID-19 vaccine to its population as coronavirus case …
Pharmafile.com’s weekly COVID-19 news round-up
December 23, 2020Research and Development COVID-19, Vaccine
The United States’ mission to inoculate its population is well underway this week; not only has the FDA given emergency …
Vicore Pharma study suggests C21 could complement COVID-19 vaccines
December 23, 2020Research and Development COVID-19, Vicore Pharma
Vicore Pharma, a Swedish company focused on developing medicines for severe lung disorders, has published data suggesting that its oral …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
